122 related articles for article (PubMed ID: 2865262)
1. Development of selective inhibitors of transglutaminase. Phenylthiourea derivatives.
Lee KN; Fesus L; Yancey ST; Girard JE; Chung SI
J Biol Chem; 1985 Nov; 260(27):14689-94. PubMed ID: 2865262
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of phenylthiourea derivatives as inhibitors of transglutaminase-catalyzed reaction in Chinese hamster ovary cells.
Lee KN; Chung SI; Girard JE; Fesus L
Biochim Biophys Acta; 1988 Nov; 972(2):120-30. PubMed ID: 2903774
[TBL] [Abstract][Full Text] [Related]
3. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
Achyuthan KE; Dobson JV; Greenberg CS
Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
[TBL] [Abstract][Full Text] [Related]
4. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transglutaminase by synthetic tyrosine melanin.
Ikura K; Otomo C; Natsuka S; Ichikawa A; Wakamatsu K; Ito S; Taoguchi S
Biosci Biotechnol Biochem; 2002 Jun; 66(6):1412-4. PubMed ID: 12162571
[TBL] [Abstract][Full Text] [Related]
6. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
Jeleńska MM; Fesüs L; Kopeć M
Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
[TBL] [Abstract][Full Text] [Related]
7. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
Gorman JJ; Folk JE
J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325
[TBL] [Abstract][Full Text] [Related]
8. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin.
Valnickova Z; Enghild JJ
J Biol Chem; 1998 Oct; 273(42):27220-4. PubMed ID: 9765243
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
Borth W; Chang V; Bishop P; Harpel PC
J Biol Chem; 1991 Sep; 266(27):18149-53. PubMed ID: 1680857
[TBL] [Abstract][Full Text] [Related]
10. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme.
Gorman JJ; Folk JE
J Biol Chem; 1984 Jul; 259(14):9007-10. PubMed ID: 6146608
[TBL] [Abstract][Full Text] [Related]
11. Expression of guinea-pig liver transglutaminase cDNA in Escherichia coli. Amino-terminal N alpha-acetyl group is not essential for catalytic function of transglutaminase.
Ikura K; Tsuchiya Y; Sasaki R; Chiba H
Eur J Biochem; 1990 Feb; 187(3):705-11. PubMed ID: 1968007
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic and kinetic properties of blood coagulation factor XIIIa and guinea pig liver transglutaminase utilizing (6-[N-(4-aminobutyl)-N-ethylamino]-2,3-dihydrophthalazine-1,4-dione, as a novel, specific and sensitive chemiluminescent substrate.
Achyuthan KE
J Biolumin Chemilumin; 1998; 13(1):1-11. PubMed ID: 9608360
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel dipeptide-bound alpha,beta-unsaturated amides and epoxides as irreversible inhibitors of guinea pig liver transglutaminase.
Marrano C; de Macédo P; Keillor JW
Bioorg Med Chem; 2001 Jul; 9(7):1923-8. PubMed ID: 11425595
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.
Marrano C; de Macédo P; Gagnon P; Lapierre D; Gravel C; Keillor JW
Bioorg Med Chem; 2001 Dec; 9(12):3231-41. PubMed ID: 11711299
[TBL] [Abstract][Full Text] [Related]
15. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate.
Slaughter TF; Achyuthan KE; Lai TS; Greenberg CS
Anal Biochem; 1992 Aug; 205(1):166-71. PubMed ID: 1359806
[TBL] [Abstract][Full Text] [Related]
16. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
[TBL] [Abstract][Full Text] [Related]
17. Specificity of guinea pig liver transglutaminase for amine substrates.
Lorand L; Parameswaran KN; Stenberg P; Tong YS; Velasco PT; Jönsson NA; Mikiver L; Moses P
Biochemistry; 1979 May; 18(9):1756-65. PubMed ID: 35225
[TBL] [Abstract][Full Text] [Related]
18. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
[TBL] [Abstract][Full Text] [Related]
19. A fluorescent substrate of transglutaminase for detection and characterization of glutamine acceptor compounds.
Pasternack R; Laurent HP; Rüth T; Kaiser A; Schön N; Fuchsbauer HL
Anal Biochem; 1997 Jun; 249(1):54-60. PubMed ID: 9193708
[TBL] [Abstract][Full Text] [Related]
20. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides.
Gorman JJ; Folk JE
J Biol Chem; 1981 Mar; 256(6):2712-5. PubMed ID: 6110660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
